-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Biotechnology Channel News: About 5 million elderly people around the world appear shaking hands and feet, slow movement, muscle stiffness and other symptoms, in serious cases, basic life can not take care of themselves.
about 40 percent of the population had anxiety symptoms and about 30 percent had depressive symptoms.
this group is often thought to have a brain disease.
for this brain disease, medical methods appear pale and weak, can only alleviate its symptoms, finding the cause has been the subject of medical research.
recent breakthrough in this area by U.S. researchers: one of the "culprits" of this brain disease is the gut bacteria.
the gut microbiome is an important pusher, the body's motor function deteriorates, may be caused by changes in the gut microbiome or the gut bacteria themselves.
new findings mean doctors have a new way to treat the brain disease, starting with the gut.
such as regulating short-chain fatty acid levels, taking probiotics, or removing harmful microorganisms.
also provide a solid theoretical basis for preventing and mitigating this brain disease.
Ruiju probiotic yuan, adjust the micro-ecological balance in the intestines, so that the growth of intestinal bigibacteria several times, inhibit the production of harmful bacteria, the production of broken-chain fatty acids and synthetic B vitamins, reduce the deposition of harmful substances.
The human intestine has about 10 trillion microorganisms, is 5 to 10 times the human cells, the total number of genes about 300,000, but also more than 10 times the human body, in these microorganisms, beneficial bacteria, harmful bacteria, neutral bacteria
in the long-term evolution process, the intestinal bacteria are always in a dynamic equilibrium state, and the bacterial structure is relatively stable.
the proportion of beneficial bacteria in the intestines of strong people reached 70%, the average person is 25%, and the proportion of probiotics in the intestines of cancer patients is only 10%, it is particularly important to increase the proportion of beneficial bacteria.
However, with probiotics, probiotics do not multiply, probiotics do not multiply, then it does not play its due role, which requires the addition of Ruiju probiotics, probiotics can proliferate probiotics, probiotics increase in number, can the effect of probiotics, play to the maximum.
May 13, 2016, the United States launched a new National Microbiome Program to provide scientific evidence that all chronic disease processes are closely related to gut microbes.
more than 70% of the body's mucous membranes are immune, and through complex immune mechanisms, the intestinal and intestinal bacteria are closely linked to organs in various parts of the body.
immune molecules and metabolites are the "bridges" between the gut bacteria and the brain, with 80 to 90 percent of the nerve fibers in the intestinal nervous system linking the intestines to the brain.
produces a short-chain fatty acid when the gut bacteria break down foods such as dietary fiber.
short-chain fatty acids can promote intestinal peristaltic, promote detocation, reduce the deposition of harmful substances, increase the body's immunity.
Ruiju probiotic yuan is soluble dietary fiber, is the human body can not digest and absorb carbohydrates, in the intestines can choose to multiply probiotics (double gicobacteria, lactic acid bacteria, etc.) and can not be used by harmful bacteria.
.